These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 10756536

  • 1. Loteprednol etabonate: a review of ophthalmic clinical studies.
    Howes JF.
    Pharmazie; 2000 Mar; 55(3):178-83. PubMed ID: 10756536
    [Abstract] [Full Text] [Related]

  • 2. Treatment of ocular inflammatory conditions with loteprednol etabonate.
    Pavesio CE, Decory HH.
    Br J Ophthalmol; 2008 Apr; 92(4):455-9. PubMed ID: 18245274
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Change in intraocular pressure during long-term use of loteprednol etabonate.
    Novack GD, Howes J, Crockett RS, Sherwood MB.
    J Glaucoma; 1998 Aug; 7(4):266-9. PubMed ID: 9713785
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A double-masked, placebo-controlled evaluation of the efficacy and safety of loteprednol etabonate in the treatment of giant papillary conjunctivitis.
    Asbell P, Howes J.
    CLAO J; 1997 Jan; 23(1):31-6. PubMed ID: 9001768
    [Abstract] [Full Text] [Related]

  • 7. Safety and efficacy of loteprednol etabonate for treatment of papillae in contact lens-associated giant papillary conjunctivitis.
    Bartlett JD, Howes JF, Ghormley NR, Amos JF, Laibovitz R, Horwitz B.
    Curr Eye Res; 1993 Apr; 12(4):313-21. PubMed ID: 8319490
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A double-masked, placebo-controlled evaluation of 0.5% loteprednol etabonate in the treatment of postoperative inflammation. The Loteprednol Etabonate Postoperative Inflammation Study Group 2.
    Ophthalmology; 1998 Sep; 105(9):1780-6. PubMed ID: 9754192
    [Abstract] [Full Text] [Related]

  • 10. Double-masked, placebo-controlled evaluation of loteprednol etabonate 0.5% for postoperative inflammation. Loteprednol Etabonate Post-operative Inflammation Study Group 1.
    Stewart R, Horwitz B, Howes J, Novack GD, Hart K.
    J Cataract Refract Surg; 1998 Nov; 24(11):1480-9. PubMed ID: 9818338
    [Abstract] [Full Text] [Related]

  • 11. Long-term safety of loteprednol etabonate 0.2% in the treatment of seasonal and perennial allergic conjunctivitis.
    Ilyas H, Slonim CB, Braswell GR, Favetta JR, Schulman M.
    Eye Contact Lens; 2004 Jan; 30(1):10-3. PubMed ID: 14722462
    [Abstract] [Full Text] [Related]

  • 12. A double-masked, placebo-controlled evaluation of the efficacy and safety of loteprednol etabonate in the treatment of giant papillary conjunctivitis. The Loteprednol Etabonate Giant Papillary Conjunctivitis Study Group I.
    Friedlaender MH, Howes J.
    Am J Ophthalmol; 1997 Apr; 123(4):455-64. PubMed ID: 9124242
    [Abstract] [Full Text] [Related]

  • 13. A controlled evaluation of the efficacy and safety of loteprednol etabonate in the prophylactic treatment of seasonal allergic conjunctivitis. Loteprednol Allergic Conjunctivitis Study Group.
    Dell SJ, Shulman DG, Lowry GM, Howes J.
    Am J Ophthalmol; 1997 Jun; 123(6):791-7. PubMed ID: 9535623
    [Abstract] [Full Text] [Related]

  • 14. Controlled evaluation of loteprednol etabonate and prednisolone acetate in the treatment of acute anterior uveitis. Loteprednol Etabonate US Uveitis Study Group.
    Am J Ophthalmol; 1999 May; 127(5):537-44. PubMed ID: 10334346
    [Abstract] [Full Text] [Related]

  • 15. Loteprednol etabonate: comparison with other steroids in two models of intraocular inflammation.
    Howes JF, Baru H, Vered M, Neumann R.
    J Ocul Pharmacol; 1994 May; 10(1):289-93. PubMed ID: 8207332
    [Abstract] [Full Text] [Related]

  • 16. Intraocular pressure elevations with loteprednol etabonate: a retrospective chart review.
    Rajpal RK, Digby D, D'Aversa G, Mah F, Hollander DA, Conway T.
    J Ocul Pharmacol Ther; 2011 Jun; 27(3):305-8. PubMed ID: 21574815
    [Abstract] [Full Text] [Related]

  • 17. Attenuation of ocular hypertension with the use of topical loteprednol etabonate 0.5% in steroid responders after corneal transplantation.
    Holland EJ, Djalilian AR, Sanderson JP.
    Cornea; 2009 Dec; 28(10):1139-43. PubMed ID: 19770719
    [Abstract] [Full Text] [Related]

  • 18. Impact of the Topical Ophthalmic Corticosteroid Loteprednol Etabonate on Intraocular Pressure.
    Sheppard JD, Comstock TL, Cavet ME.
    Adv Ther; 2016 Apr; 33(4):532-52. PubMed ID: 26984315
    [Abstract] [Full Text] [Related]

  • 19. Management of seasonal allergic conjunctivitis: guide to therapy.
    Bielory BP, O'Brien TP, Bielory L.
    Acta Ophthalmol; 2012 Aug; 90(5):399-407. PubMed ID: 22067457
    [Abstract] [Full Text] [Related]

  • 20. Loteprednol and tobramycin in combination: a review of their impact on current treatment regimens.
    Comstock TL, Holland EJ.
    Expert Opin Pharmacother; 2010 Apr; 11(5):843-52. PubMed ID: 20210687
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.